168 related articles for article (PubMed ID: 37460111)
21. Stimuli responsive nanosonosensitizers for sonodynamic therapy.
Jiang Z; Xiao W; Fu Q
J Control Release; 2023 Sep; 361():547-567. PubMed ID: 37567504
[TBL] [Abstract][Full Text] [Related]
22. Lipid bilayer-based biological nanoplatforms for sonodynamic cancer therapy.
Li S; Mok GSP; Dai Y
Adv Drug Deliv Rev; 2023 Nov; 202():115110. PubMed ID: 37820981
[TBL] [Abstract][Full Text] [Related]
23. Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.
Yang Y; Huang J; Liu M; Qiu Y; Chen Q; Zhao T; Xiao Z; Yang Y; Jiang Y; Huang Q; Ai K
Adv Sci (Weinh); 2023 Jan; 10(2):e2204365. PubMed ID: 36437106
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in sonodynamic immunotherapy.
Du JR; Wang Y; Yue ZH; Zhang HY; Wang H; Sui GQ; Sun ZX
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1645-1656. PubMed ID: 35831762
[TBL] [Abstract][Full Text] [Related]
26. Engineering Fe/Mn-doped zinc oxide nanosonosensitizers for ultrasound-activated and multiple ferroptosis-augmented nanodynamic tumor suppression.
Hu Z; Song X; Ding L; Cai Y; Yu L; Zhang L; Zhou Y; Chen Y
Mater Today Bio; 2022 Dec; 16():100452. PubMed ID: 36245834
[TBL] [Abstract][Full Text] [Related]
27. Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity.
Wang T; Peng W; Du M; Chen Z
Front Oncol; 2023; 13():1167105. PubMed ID: 37168380
[TBL] [Abstract][Full Text] [Related]
28. 'Mito-Bomb': a novel mitochondria-targeting nanosystem for ferroptosis-boosted sonodynamic antitumor therapy.
Wang J; Zhao Z; Liu Y; Cao X; Li F; Ran H; Cao Y; Wu C
Drug Deliv; 2022 Dec; 29(1):3111-3122. PubMed ID: 36131565
[TBL] [Abstract][Full Text] [Related]
29. Bioreducible exosomes encapsulating glycolysis inhibitors potentiate mitochondria-targeted sonodynamic cancer therapy via cancer-targeted drug release and cellular energy depletion.
Nguyen Cao TG; Truong Hoang Q; Kang JH; Kang SJ; Ravichandran V; Rhee WJ; Lee M; Ko YT; Shim MS
Biomaterials; 2023 Oct; 301():122242. PubMed ID: 37473534
[TBL] [Abstract][Full Text] [Related]
30. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
31. Bacteria-driven nanosonosensitizer delivery system for enhanced breast cancer treatment through sonodynamic therapy-induced immunogenic cell death.
Du M; Wang T; Peng W; Feng R; Goh M; Chen Z
J Nanobiotechnology; 2024 Apr; 22(1):167. PubMed ID: 38610042
[TBL] [Abstract][Full Text] [Related]
32. Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy.
Li J; Yue Z; Tang M; Wang W; Sun Y; Sun T; Chen C
Adv Healthc Mater; 2024 Jan; 13(1):e2302028. PubMed ID: 37672732
[TBL] [Abstract][Full Text] [Related]
33. Imaging-guided focused ultrasound-induced thermal and sonodynamic effects of nanosonosensitizers for synergistic enhancement of glioblastoma therapy.
Wan Q; Zou C; Hu D; Zhou J; Chen M; Tie C; Qiao Y; Yan F; Cheng C; Sheng Z; Zhang B; Liu X; Liang D; Zheng H
Biomater Sci; 2019 Jun; 7(7):3007-3015. PubMed ID: 31112151
[TBL] [Abstract][Full Text] [Related]
34. M1 Macrophage-Derived Sonoresponsive Nanoparticles for Sonodynamic Anticancer Therapy.
Chen S; Wang J; Liao H; Tang K; Xu Y; Wang L; Niu C
Int J Nanomedicine; 2022; 17():4725-4741. PubMed ID: 36246937
[TBL] [Abstract][Full Text] [Related]
35. A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy.
Jiang Q; Qiao B; Lin X; Cao J; Zhang N; Guo H; Liu W; Zhu L; Xie X; Wan L; Tang R; Liang B; Wang D; Wang Z; Zhou Y; Ran H; Li P
Theranostics; 2022; 12(1):59-75. PubMed ID: 34987634
[TBL] [Abstract][Full Text] [Related]
36. Autophagy blockade synergistically enhances nanosonosensitizer-enabled sonodynamic cancer nanotherapeutics.
Zhou L; Huo M; Qian X; Ding L; Yu L; Feng W; Cui X; Chen Y
J Nanobiotechnology; 2021 Apr; 19(1):112. PubMed ID: 33879173
[TBL] [Abstract][Full Text] [Related]
37. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
[TBL] [Abstract][Full Text] [Related]
38. Nanoenabled Tumor Energy Metabolism Disorder via Sonodynamic Therapy for Multidrug Resistance Reversal and Metastasis Inhibition.
Guo X; Tu P; Zhu L; Cheng C; Jiang W; Du C; Wang X; Qiu X; Luo Y; Wan L; Tang R; Ran H; Wang Z; Ren J
ACS Appl Mater Interfaces; 2023 Jan; 15(1):309-326. PubMed ID: 36576435
[TBL] [Abstract][Full Text] [Related]
39. Oxygen-Deficient Tungsten Oxide (WO
Zhou Y; Yang N; Gong F; Wang Y; Yang X; Dai Y; Yu Q; Wang L; Chen W; Zhuo M; Cheng L
ACS Nano; 2022 Oct; 16(10):17242-17256. PubMed ID: 36170351
[TBL] [Abstract][Full Text] [Related]
40. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
